Browsing by Author "Babat, N."

Now showing 1 - 7 of 7

Assessment of Vitamin D Levels in Patients With Acute Coronary Syndrome
(Yuzuncu Yil Universitesi Tip Fakultesi, 2016) Simsek, H.; Babat, N.
In recent studies, vitamin D is claimed to have positive effects for acute coronary syndrome (ACS) by decreasing states that are accepted as important risk factors for ACS development such as endothelial damage, high blood pressure, insulin resistance, diabetes development and vascular inflammation. We have investigated the relation between ACS and plasma vitamin D levels in this study. The study was conducted with a total number of 90 patients diagnosed with ACS and 50 individuals with normal coronary artery angiography. No significantly different plasma vitamin D levels of control group was detected compared to the patients with ACS (Mean=15.2±4.8 versus 15.3±6.3ng/ml, p>0.05). Significant difference related to smoking prevalence was detected between the two groups (52.8% versus 20%, p<0.01). We have concluded that Vitamin D insufficiency does not increase the risk for development of ACS significantly, after the corrections related to blood cholesterol elevation, smoking, diabetes, high blood pressure, family history. According to these results, there was no association between the plasma level of vitamin D and the risk of development of ACS. © 2017 Yuzuncu Yil Universitesi Tip Fakultesi. All rights reserved.
The Clinical Features, Risk Factors and Treatment Methods of Patients With Acute Coronary Syndrome
(Excerpta Medica inc-elsevier Science inc, 2014) Aladag, N.; Yurtdas, M.; Ozdemir, M.; Gonullu, H.; Babat, N.; Demir, G.; Gumrukcuoglu, H.
Evaluation of Cardiology Consultations During the Covid-19 Pandemic Period
(Yuzuncu Yil Universitesi Tip Fakultesi, 2021) Babat, N.; Duz, R.; Karaduman, M.; Tuncer, M.
In this study, we scientifically examined the consultations of the patients being hospitalized from the other departments to the cardiology department during Coronavirus Disease 2019 (COVID-19) pandemia. Consultations to the cardiology department between 01 April-31 May 2020 and 01 April-31 May 2019 were discussed. Demographic characteristics and reasons of consultations were compared. A different approach was f ollowed in COVID-19 patients diagnosed with compared to patients in other clinics. The rate of consulted patients in 2019 year was 14.4% (866/5989). Its rate in 2020 year was found as 18.5% (462/2486) (p: <0.001). A statistically significant difference was obtained in both groups. The use of drugs prolonging the Qt, preoperative and increase in cardiac enzymes were found statistically significant in terms of the consultations (p: <0.001-<0.001-0.003-0.016, respectively). Face to face interviews were made in 29% (33/114) of the patients who were consulted from COVİD-19 clinics. In 71% (81/114) patients, electrocardiography (ECG) s were evaluated digitally. In this study, although there was a decrease in the number of hospitalized patients during the COVİD-19 pandemia, we observed an increase in the number of patients being consulted to cardiology clinic. The relationship between COVİD-19 disease and cardiovascular diseases and drugs being used in the treatment increased the workload of the cardiology clinic during the pandemic period. © 2021, Yuzuncu Yil Universitesi Tip Fakultesi. All rights reserved.
The First Three Years of Ablation Therapy in Cardiac Arrhythmias: Single Centre Experience
(Yuzuncu Yil Universitesi Tip Fakultesi, 2020) Turkmen, Y.; Babat, N.
Improvements in both evaluation of intracardiac signals and molecular data yielded an easy understanding of complex cardiac arrhythmias and channelopathies in last years. However, the mentioned techniques are not applicable by all health providers because of high costs, requirement of well-educated team members, and the most importantly the presence of long learning curve for cardiologists In this article, the catheter ablation of arrhythmias in the Van Yuzuncu Yil University Department of Cardiology in last three years will be reviewed. Intracardiac signals were filtered at 20-500 Hz, amplification gains were 10-80 mm/mV. All signals displayed and acquired on an electrophysiological recording system (EP-TRACER 2 system, Schwarzer Cardiotek, Germany). All types of arrhythmias such as atrioventricular nodal reentry tachycardia, atrioventricular reentry tachycardia, atrial flutter, atrial tachycardias, atrial fibrillation, premature ventricular contractions, and ventricular tachycardias were ablated according to the latest quidelines and techniques. A total of 430 patients were screened in this trial. The success rate in the ablation of atrioventricular nodal reentry tachycardia, atrioventricular reentry tachycardia, atrail flutter, atrial tachycardias, atrial fibrillation, premature ventricular contractions, and ventricular tachycardias was 100%, 88.2%, 88.8%, 72.2%, 100%, 73.9%, and 87.5% respectively. There was only one death among 430 ablation procedures in our centre and the reason of death was not clear because of patient’s other co-morbidities. Otherwise, our success and complication rates were similar with the results of most advanced centres in all around of the world. © 2020, Yuzuncu Yil Universitesi Tip Fakultesi. All rights reserved.
A Novel Echocardiographic Method for Assessing Arterial Stiffness in Obstructive Sleep Apnea Syndrome
(Oxford Univ Press, 2015) Akdag, S.; Akyol, A.; Cakmak, H. A.; Gunbatar, H.; Asker, M.; Babat, N.; Gumrukcuoglu, H. A.
Post Covid-19 Evaluation of Patients With Cardiac Complaints by Using Echocardiography
(Yuzuncu Yil Universitesi Tip Fakultesi, 2024) Duz, R.; Çoldur, R.; Babat, N.
The aim of the study was to evaluate the presenting complaint, cardiovascular sequelae prevalence and type and demographic characteristics of patients who had no previous disease and had cardiac complaints after COVID-19, and to show the presence of cardiac sequelae objectively by evaluating every patient without chronic diseases by echocardiography and electrocardiography. In this study, we evaluated symptomatic patients by using echocardiography. In this study, there were included patients who recovered from COVID-19 disease and presented to the cardiology outpatient clinics. These patients were divided into two groups: those presenting within the first 30 days after recovery and those presenting between 30 and 60 days after recovery. Thirty patients who had not had COVID-19 before, who applied to the cardiology outpatient clinics, were selected as the control group. The rate of dizziness, palpitations, chest pain and blood pressure dysregulation did not differ si gnificantly between group I(patients presenting within 30 days after recovery), group II(patients presenting between 30 and 60 days after recovery), and group III(control group) (p> 0.05). Dyspnea rate in group I was significantly higher than group II and group III. There was a difference between groups in left ventricular ejection fraction. In group III, sPAP ≥ 35 mmHg ratio was significantly lower than group I and group II (p <0.05). sPAP ≥ 35 mmHg ratio did not differ significantly (p> 0.05) between group I and group II. While dyspnea was an important complaint in the first periods, it decreased over time. In addition, it was observed that right ventricular functions and left ventricular diastolic functions improved over time. It is noteworthy that there are more patients with pericardial effusion compared to the control group, which shows us that the inflammation process is continuing. © 2024, Yuzuncu Yil Universitesi Tip Fakultesi. All rights reserved.
Two Markers in Predicting the Cardiovascular Events in Patients With Polycystic Ovary Syndrome: Increased P-Wave and Qt Dispersion
(verduci Publisher, 2015) Akdag, S.; Cim, N.; Yildizhan, R.; Akyol, A.; Ozturk, F.; Babat, N.
OBJECTIVE: Polycystic ovary syndrome (PCOS) is a prevalent disease with many potential long-term cardiovascular risks. P-wave dispersion (Pdis) and QT dispersion (QTdis) have been shown to be noninvasive electrocardiographic predictors for development of cardiac arrhythmias. In this study we aimed to search Pdis and QTdis parameters in patients with PCOS. PATIENTS AND METHODS: The study included 82 patients with PCOS and 74 age-and sex-matched healthy controls. Baseline 12-lead electrocardiographic and transthoracic echocardiographic measurements were evaluated. P-wave maximum duration (Pmax), P-wave minimum duration (Pmin), Pdis, QT interval, heart rate-corrected QT dispersion and QTdis were calculated by two cardiologists. RESULTS: Patients wirh PCOS had significantly higher QT dispersion (49.5 +/- 14.1 vs. 37.9 +/- 12.6 ms, p < 0.001), and P wave dispersion (54.2 +/- 11.4 vs. 45.9 +/- 10.1 ms, p < 0.001) than the controls. Serum testosterone and estradiol levels was correlated with the Pdis (r = 0.677, p < 0.001 and r = 0.415, p < 0.001 respectively) and QTdis (r = 0.326, p < 0.001 and r = 0.321, p < 0.001 respectively). CONCLUSIONS: Pdis and QTdis are simple and useful electrocardiographic markers which may be used in the prediction of the risk of adverse cardiovascular events in PCOS patients.